Abstract Previous data has shown that prior history of immune challenge may affect central and behavioural responses to subsequent immune challenge, either leading to exaggerated responses via priming mechanisms or lessened responses via endotoxin tolerance. In this set of experiments we have examined how previously lipopolysaccharide (LPS)-induced sepsis shapes the response to subsequent treatment with lower dose LPS. After treatment with LPS (5 mg/kg) or saline mice were allowed to recover for 3-4 months before being challenged with a lower dose of LPS (100 lg/kg) for assessment of sickness behaviours.
Introduction
Peripheral administration of the gram-negative bacterial endotoxin lipopolysaccharide (LPS) has long been recognised to produce a syndrome of behavioural changes termed sickness behaviour, including decreased locomotion and exploration, decreased food intake and increased sleep, as well as inducing increased depressive-like behaviours (McCusker and Kelley 2013) . This behaviour change may reflect an adaptive response to sickness that best allows an organism to fight off infection (Dantzer 2001) . It is believed that both peripheral neural activation and production of humoral factors in response to the immune challenge leads to induction of pro-inflammatory mediators in the brain, and it is the action of these mediators (e.g. TNF-a, IL-1b) that underpin the behavioural changes elicited by immune challenge (Dantzer et al. 2008) .
A homeostatic control system that may be of importance in sickness behaviour is the circadian system (Coogan and Wyse 2008) . Circadian rhythms are recurring patterns in a wide spectrum of physiological, endocrine, behavioural and cognitive parameters that recur with periods of approximately 24 h (Mohawk et al. 2012) . The circadian timekeeping network functions as a network of connected central and peripheral oscillators, with what is thought of as a master circadian pacemaker located to the suprachiasmatic nucleus (SCN) of the anterior hypothalamus S. T. Anderson and E. K. O'Callaghan contributed equally to the work. (Dibner et al. 2010) . The correct functioning of the circadian system is increasingly being recognised as being a key contributor to health and well being, and circadian dysfunction is linked with numerous metabolic, neurological and psychiatric disorders (Bass and Takahashi 2010; Coogan et al. 2013; McClung 2013 ). An area that may be of importance in the modulation of the circadian system during pathologies is the neuroimmune regulation of central circadian pacemakers (Coogan and Wyse 2008) . Intriguingly, from a sickness behaviour point of view, there is circadian control over the affected behavioural systems, such as sleep, locomotor control and mood (McClung 2013; Coogan and Wyse 2008) .
The nature of the behavioural response elicited by a peripheral immune challenge may be determined by the background against which that challenge is presented. For example, LPS treatment of older animals produces exaggerated sickness behaviour response when compared to younger animals (Henry et al. 2009 ). Further, ongoing neuroinflammation and/or neurodegeneration ''primes'' behavioural and central responses to immune challenge, and this may be an important mechanism in the pathophysiology of delirium (Griffin et al. 2013; Cunningham 2013) . Thus, previous neuroimmunological history may impact behavioural responses to subsequent immune challenge and central responsiveness to inflammatory mediators, and these effects may be pertinent in a wide range of clinical conditions. One such condition, of profound clinical importance, is sepsis. Sepsis is a syndrome characterised by systemic inflammation that is associated with significant mortality (Angus and van der Poll 2013) . Survivors of sepsis have been described as exhibiting an ongoing syndrome termed post-septic encephalopathy, in which there are ongoing cognitive difficulties (Semmler et al. 2013; Iwashyna et al. 2010) . Similar findings of changes in behavioural and cognitive parameters, that are also accompanied by a chronic neuroinflammation, have been described in animal models (Qin et al. 2007; Weberpals et al. 2009; O'Callaghan et al. 2012) . Given the persistent upregulation of central inflammation following sepsis, we set out to enquire whether prior sepsis would impact on both behavioural and central molecular response to peripheral LPS treatment.
Materials and methods

Animals
For the purpose of all experiments male C57BL/6 mice (Charles River, Kent, UK) aged between 8 and 16 weeks were used (N = 61 in total). Animals were group housed in a 12:12 light:dark cycle for 2 weeks prior to LPS administration. Food and water were available ad libitum and temperature was 21 ± 1°C and humidity was 50 ± 10 %. Unless housed in isolation for circadian wheel running experiments, animals remained housed in groups of 2-4 in polypropylene cages (33 cm long 9 15 cm wide 9 13 cm high) with wood chip bedding and environmental enrichment (shredded paper and cardboard tubes). All procedures were approved by the Research Ethics Committee, National University of Ireland Maynooth, and were licensed by the Department of Health and Children, Ireland under statutory instrument (SI) No. 543 of 2012 and the European directive 2010/63/EU.
LPS-induced sepsis
All saline and LPS injections were made up fresh on the treatment day, and given intraperitoneally in a final injection volume of 0.125 ml. 0.9 % sterile saline was made up fresh for control injections, while LPS (serotype 0111.B4, Sigma Ireland; Qin et al. 2007 ) was made up to a 5 mg/kg dose in sterile saline. Injections were given intraperitoneally (i.p.) between zeitgeber time (ZT) 06 and 08, where ZT0 is defined as the time of lights on. Animals were allowed to recover for at least 1 month prior to behavioural testing. Mortality and significant moribundity requiring euthanasia occurred within approximately 7 % of animals (N = 3) following the induction of sepsis.
Assessment of behaviour on the open field test and the tail suspension test
Between 3 and 4 months after the septic LPS/saline treatment, mice were treated in a counterbalanced fashion (2 weeks between treatments) with either saline or LPS (i.p; 100 lg/kg) injected at ZT2. Two hours after this treatment animals were tested on the open field test (OFT) and 9 h after treatment animals were tested on the tail suspension test (TST), as depressive-like behaviours develop over a longer period following peripheral LPS treatment compared to sickness behaviour (Dantzer et al. 2008) . For the OFT, testing occurred in an arena with a diameter of 100 cm (light intensity of 200 lux in the centre of the arena). The primary outcome of the OFT was to assess sickness behaviour in terms of locomotor behaviour, with anxiety related outcomes (time spent in centre vs. time spent in the periphery) secondary endpoints. Each animal was placed in the centre of the arena and allowed to explore for 300 s during which their distance moved, velocity in cm 2 and time spent moving were automatically tracked with Ethovision 3.1 software (Ethovision 3.1; Noldus Information Technology, Leesburg, VA). The percentage of time spent in the inner 50 % and outer 50 % of the arena were also measured. For the TST, mice were removed from the home cage and attached to a support raised 121 cm above a cage containing woodchip bedding by tape placed 1 cm from the tip of their tales for 6 min. Mice were suspended for 6 min each, with immobility being recorded throughout the entire 6 min. Immobility was defined as the complete absence of movement (Steru et al. 1985) .
Assessment of circadian rhythms in wheel running behaviour
For the purpose of behavioural monitoring of circadian rhythms, animals were individually housed in polypropylene cages (33 cm long 9 15 cm wide 9 13 cm high) equipped with steel running wheels (11.5 cm diameter) with food and water available ad libitum. The light source was standard fluorescent light bulbs with an average 150 lux luminance level in each individual cage. Cages were ventilated via axial fans to prevent the build-up of pheromones and these fans produced white noise at the level of 50 dB. In order to establish whether an altered behavioural response would be seen in post-septic animals compared to controls following a second immune challenge, 14 days after induction of sepsis or control treatment (either 5 mg/ kg LPS or saline), animals were placed into constant darkness (DD) for 14 days and allowed to free run. Animals then received either i.p. saline or an i.p. injection of LPS at a dose of 100 lg/kg at CT15. This time was chosen as it previously has been shown administration of low dose LPS at this phase induces photic like phase delays of locomotor activity (Marpegán et al. 2005) . Following treatment, the animals were maintained in DD for an additional 14 days before receiving a counterbalanced treatment of either LPS or saline at CT15. Following this treatment, the animals' activity patterns in DD were followed for 14 days and phase shifts of locomotor activity rhythms assessed. The line of best fit method was used to assess the phase shift magnitudes from the actogram data, fitting the line through activity onsets 7 days before and 10 days after treatment with LPS 100 lg/kg or vehicle. The differences between the lines from the actograms were rated by two independent researchers blind to the experimental procedure. Following each CT15 treatment, the circadian parameters of free running period and rhythm amplitude were calculated for each animal using the Chronobiology Kit Chi Squared procedure.
Immediate early gene expression and markers of microglia
In order to establish whether post-septic animals would exhibit altered immediate early gene expression following LPS treatment compared to controls, 6 week old male mice were group housed in colonies of three in cages equipped with appropriate environmental enrichment and habituated to a 12:12 LD cycle for 2 weeks (150 lux, lights on 0500 hours) prior to experimentation. The animals were treated with either LPS 5 mg/kg i.p. to induce sepsis, or saline. The animals were allowed to recover following the induction of sepsis and were maintained for 3-4 months under a 12:12 LD cycle. Both post-septic and saline treated controls then received an i.p. injection of LPS at a dose of 100 lg/kg at ZT1-2. Animals were then terminally anaesthetized and perfused transcardially with 4 % paraformaldehyde. Animals were perfused 2, 4 or 9 h after LPS treatment. Timepoints at 2 and 9 h were used for assessment of immediate early gene expression, whilst those at 4 h were used to assess microglial markers. We examined 4 h as there has been reports of changes in microglial function 4 h after LPS treatment (e.g. Chen et al. 2008; Henry et al. 2009) , and the 2 and 9 h timepoints to coincide with the times of behavioural testing. We examined the hippocampus, as sickness behaviour has been associated in a number of studies with neurochemical changes in this brain region (e.g. Frenois et al. 2007 ) and we examined the SCN given its profound importance in circadian timekeeping (Dibner et al. 2010) . Another group of animals was treated with LPS 1 month after sepsis treatment and sampled 4 h after LPS and these animals' brains were later used for the assessment of microglial markers.
Following cryoprotection in 30 % sucrose brains were coronally sectioned (30 lm sections) on a freezing sliding stage microtome (Leica, Germany) and then sections processed according to a standard avidin-biotin complex nickel DAB immunohistochemical protocol (see Beynon and Coogan 2010) . All sections processed for the same antigens were processed in parallel across experimental groups. The primary antibodies used in this study were: c-Fos, Santa Cruz Biotechnology (sc-52), rabbit polyclonal, used at 1:2,000; EGR1, Santa Cruz Biotechnology, rabbit polyclonal (sc-189), 1:3,000; Cd-11b, ABD Serotec (MCA74GA), rabbit polyclonal, used at 1:1,000; F4/80, ABD Serotec (MCA497GA), rabbit polyclonal used at 1:100 and IL-1b Peprotech (500 P-51), rabbit polyclonal used at 1:50.
Photomicrographs of hippocampus and SCN were taken using a digital camera connected to an Olympus BX-51 light microscope equipped with an image analysis digital system (ImageJ 1.43, NIH, USA). All images were taken using the same camera and magnification settings. For analysis, brain sections were examined under either the 109 or 409 objective lens. Between 3 and 6 bilateral images were evaluated for each individual animal and region depending on the area being examined and a mean value obtained for each animal for each region. Only sections from the mid rostrocaudal level of the SCN were examined (hence limiting the number of sections available from any one animal) and for the hippocampus 4 to 6 bilateral sections per animal of the medial dorsoventral axis of the hippocampus were analysed. Immunoreactive cells in each region of interest were quantified using quantification of immunoreactive (ir) cell number by an observer by by-eye counting for the purpose of analysing immunoreactive nuclear staining for c-Fos and EGR1. The observer was blinded to the experimental procedure during optical density measurements or quantification of immunoreactive cells. A previously described method for assessing glia whereby the image was binarised for analysis was used for integrated optical density measurements (Vilaplana and Lavialle 1999 ) was used to assess staining levels for Cd11b, F4/80 and IL-1b.
Statistics
All data values given are mean ± SEM. Inferential statistical analysis was via factorial between groups or mixed between-within groups ANOVAs and t tests as appropriate (paired or independent). P \ 0.05 was deemed statistically significant. Where multiple comparisons were carried out the appropriate Bonferroni correction was applied.
Results
Mice tested on the OFT showed decreased exploration (as assessed by time spent mobile, distance travelled and velocity) following LPS treatment, irrespective of whether they had previously undergone sepsis or not ( Fig. 1a ; P \ 0.001 for each dependent variable for main effect of acute LPS). However ANOVA reveals no significant sepsis effect or sepsis 9 LPS interactions on measures of distance travelled, time spent mobile or velocity for any of the dependent variables analysed. When areas of the open field explored were analysed we found there was a significant difference in exploration of the periphery versus the centre, with animals spending less time in the centre following LPS than saline treatment (F 1,14 = 7.4, P \ 0.05 for main effect of acute LPS on time spent in the centre). However there was no effect of prior sepsis nor a sepsis 9 LPS treatment interaction (P = 0.31 and P = 0.39 respectively) indicating that prior sepsis did not alter the extent to which animals exploration of the open field was altered following an acute peripheral LPS challenge. When examined on the TST, both animals that had previously undergone sepsis and those that had not showed increased immobility following LPS compared to saline treatment (F 1,14 = 17, P \ 0.001 for main effect of acute LPS treatment; Fig. 1c) . However there was no interaction effect of prior sepsis on the immobility subsequently induced by LPS treatment (P = 0.65) and pairwise comparisons indicate that LPS induces significantly more immobility than saline treatment in both control and post-septic animals. Therefore the results from these experiments indicate that prior sepsis does not affect behavioural responses to a 100 lg/kg treatment of LPS as measured on the OFT and the TST. We analysed immediate early gene expression at 2 and 9 h following LPS treatment in post-septic and control animals. In the hippocampus there were significant main effects of sepsis on c-Fos expression in the dentate gyrus and the CA1 (F 1,15 = 6.47, P \ 0.05 and F 1,15 = 7.01, P \ 0.05 respectively). Pairwise analysis reveals a significant upregulation of c-Fos in the dentate gyrus at 2 h in post-septic animals and a decrease in the CA1 in postseptic animals 9 h after LPS treatment (Fig. 2a, b) . When EGR-1 was examined, there was a main effect of sepsis on EGR1 expression following acute LPS treatment in the dentate gyrus and the CA1 (F 1,15 = 7.7, P \ 0.05 and F 1,15 = 4.9, P \ 0.05 respectively). Pairwise analysis reveals EGR1 expression at 2 h following LPS treatment in the CA1 was enhanced in post-septic animals compared to controls (Fig. 2c, d ). We then examined microglial marker expression in both post-septic (1 month after sepsis) and control animals following a peripheral LPS challenge. In the hippocampus we observed that expression of both Cd11b and F4/80 was higher in post-septic animals than in controls (Fig. 3) . When expression of the pro-inflammatory cytokine IL-1b was examined there was no difference in its expression in the hippocampus between post-septic animals and controls following LPS treatment at either 2 or 9 h (Fig. 4) .
When tested for phase shifts of their circadian rhythms in response to LPS treatment, animals that had previously not undergone sepsis showed a moderate phase delay of the free running rhythm after treatment with LPS at CT15 (-0.68 ± 0.14 h for LPS vs. -0.10 ± 0.07 h for saline treatment; P \ 0.05; Fig. 5 ). There was no change in free running period or rhythm power following LPS treatment, nor any differences between the post-septic and control groups (data not shown). For post-septic animals LPS treatment did not elicit a significant phase shift compared to control saline treatment (-0.22 ± 0.08 h for LPS treated animals compared to -0.25 ± 0.13 h for saline treatment). ANOVA revealed a main effect for shift magnitude elicited by the LPS (F 1,20 = 6.79, P \ 0.05) and an interaction effect for prior sepsis and acute LPS (F 1,20 = 8.65, P \ 0.01).
There were no differences in the expression of c-Fos or EGR-1 in the SCN of post-septic animals compared to controls following LPS treatment (Fig. 6 ) and further there was also no difference in either Cd-11b or F4/80 expression after LPS treatment in the SCN of control and postseptic animals (Fig. 7) . 
Discussion
This study explored how prior sepsis might impinge on behavioural and molecular responses to subsequent immune challenge. Previous studies to date have shown that in mice, induction of sepsis with a 5 mg/kg dose of LPS induces a long-lasting neuroinflammation (Qin et al. 2007; Weberpals et al. 2009; O'Callaghan et al. 2012; Bossù et al. 2012) . Further it has been reported that in animals who have previously undergone sepsis that there are persistent changes in neurophysiological, cognitive and behavioural parameters (Calsavara et al. 2013; Iwashyna et al. 2010; Weberpals et al. 2009; O'Callaghan et al. 2012) . These changes appear to model the syndrome of post-septic encephalopathy in patients who have survived sepsis and who display cognitive impairments after discharge from hospital when compared to patients who have spent similar durations in intensive care wards due to other conditions (Semmler et al. 2013; Siami Iwashyna et al. 2010) . Animal studies of models of neurodegeneration have indicated that the ongoing process of neuronal cell death, coupled with concomitant neuroinflammation, primes microglia for exaggerated responses to peripheral immune challenge and leads to more exacerbated behavioural and cognitive effects than would normally be elicited by such an immune challenge against a normal neuroimmunological background (reviewed by Cunningham 2013) . Further, immune challenge in healthy older animals leads to an exaggerated behavioural response, and aging in associated with increased neuroinflammation (Norden and Godbout 2013) . Therefore we set out to examine whether the neuroinflammation observed postsepsis in the mouse might be associated with altered responses to LPS. The open field test is a mainstay of assessing sickness behaviour that follows from peripheral immune challenge, as it allows for motor activity and exploration to be observed in the same task (Yirmiya et al. 1994 ). In our study we found the expected suppression by LPS of locomotion and exploration in the OFT, although we found no evidence that prior sepsis affected this. Further, as LPS treatment induces a depressive-like state with a delayed time course compared to sickness behaviour (Dantzer et al. 2008) , we tested response to acute LPS on the TST, a well validated model of behavioural despair (Cryan et al. 2005) . We observed the expected LPS-induced increase in immobility, but again found no evidence for altered responses to LPS in post-septic animals. It may be that prior sepsis simply does not affect the behavioural expression of subsequent LPS-induced behaviours, or it may be that the acute LPS dose used in the current study (100 lg/kg), which induces a mild to moderate sickness behaviour (Cunningham et al. 2005 ) is not the optimal dose to use, and that increased sensitivity to a lower dose of LPS may be seen in post-septic animals; future experiments will need to address such issues.
It is also interesting to note that whilst we observed no behavioural impacts of prior sepsis on LPS-induced effects, we did observe some changes in immediate early gene expression, with significant changes in c-Fos and EGR1 expression observed in the hippocampus of post-septic animals following acute LPS treatment compared to control non-sepsis animals treated with LPS. Previous data has shown that forebrain c-Fos expression is induced by acute LPS treatment in the mouse (Frenois et al. 2007 ) and EGR1 expression in the forebrain is also altered acutely by LPS treatment (Bonow et al. 2009; Gavilán et al. 2009 ). The functional relevance of altered c-Fos and EGR1 expression in the hippocampus after acute LPS treatment in post-septic animals is unclear. EGR1 has been implicated as a plasticity-associated mediator reported to be important in longterm memory (Davis et al. 2003 ) and it will be of interest in the future to assess acute LPS-induced effects on memory formation and recall in behavioural tasks such as the Morris water maze in post-septic animals, as acute LPS is well described as inducing cognitive deficits in such tasks (Shaw et al. 2001 ). An interesting precedent is found in the expression of another plasticity-associated immediate early gene product, ARC, whose expression in the dentate gyrus is upregulated in a model of chronic neuroinflammation involving ongoing central injection of LPS, with this upregulation being associated with impaired performance on spatial memory tasks (Hauss-Wegrzyniak et al. 1998; Rosi et al. 2005) . The changes in c-Fos and EGR1 expression in the post-septic animals may represent an For the analysis of circadian responses to acute LPS treatment, we built on observations that peripheral LPS treatment induces moderate phase delays of the free-running rhythm of locomotor behaviour, but only when LPS is applied at CT15 (in the early portion of the activity phase; Marpegán et al. 2005 ). This effect of acute LPS is dependent on TLR4 (Paladino et al. 2010) and involves the central action of TNF-a (Leone et al. 2012) . Further the SCN has been shown to be sensitive to peripheral immune challenge, with SCN levels of activated NF-jB p65, c-Fos and EGR1 acutely-induced by peripheral LPS treatment (Beynon and Coogan 2010; O'Callaghan et al. 2012 ). Further we have previously described changes in circadian clock resetting in post-septic animals (O'Callaghan et al. 2012 ). To our surprise we observed that treatment of postseptic animals with acute LPS did not result in any significant phase shift, in comparison to control animals who displayed the expected phase delays. We do not believe that there is an explanation offered for such findings in the alteration of core circadian parameters in post-septic animals, as in the current studies and in previous studies (O'Callaghan et al. 2012) we do not find alterations in free running period, rhythm power or other core circadian parameters. One possible explanation for the lack of effect of acute LPS effects on the circadian system in post-septic animals is the immunosuppression following from sepsis (Hotchkiss et al. 2013 ) and/or from endotoxin tolerance (Morris and Li 2012) . Such effects seem somewhat unlikely, given that the timeframe between the septic LPS treatment and the shortest time to the acute LPS treatment is 4 weeks, by which time it would LPS-tolerance would be expected to have dissipated (West and Heagy 2002) . Further, the results from the open field and tail suspension tests indicate that LPS induces the same levels of behavioural effects in post-septic animals as in controls, suggesting that post-septic mice, at the time of testing used in our experiments, are capable of producing appropriate behavioural responses to further LPS challenge. Therefore it is not clear as to the mechanisms by which there is an altered circadian response to LPS in post-septic animals, and if this effect is specific to the circadian system or is a secondary effect of a more universal change. For example, Weberpals et al. (2009) described changes in cerebral metabolism in postseptic mice, and such changes may have an impact on the response of the SCN to LPS. Further, loss of dendritic spines has been described post-LPS in mice (Kondo et al. 2011) , and such a loss might induce a functional rearrangement in the SCN and different characteristics of phase resetting, as a previous study demonstrated altered resetting in post-septic animals (O'Callaghan et al. 2012 ). There were no apparent differences in the levels of c-Fos or EGR1 in the SCN following on from an acute LPS treatment in post-septic animals, although it should be noted that for this analysis that LPS treatment occurred during the subjective day, and not at CT15 which is the time of treatment used to elicit behavioural phase shifts. We chose this time of treatment as previous work had indicated that acute LPS treatment during the subjective day can upregulate SCN expression of both c-Fos and EGR1 (Beynon and Coogan 2010; O'Callaghan et al. 2012) .
The analysis of the microglial markers F4/80 and Cd-11b indicate that there is no difference in their expression in the SCN following acute LPS treatment between post-septic and control animals. However we do report a finding that levels of both these antigens are elevated in the hippocampus following acute LPS treatment in post-septic animals. It may be that microglia are more reactive to subsequent challenge in post-septic animals, and that this effects is region-specific, or it may reflect a general upregulation of microglial markers in the post-septic hippocampus (e.g. Weberpals et al. 2009 ), or a combination of the two. Our finding that hippocampal IL1b levels are not enhanced may be taken to indicate that microglia are not more responsive, as priming experiments have previously shown upregulation of IL-1b in microglia following LPS treatment against a background of neurodegeneration (Cunningham et al. 2005) .
Overall, this study indicates that prior LPS-induced sepsis has some modality-specific effects on behavioural response to subsequent immune challenge. Future work may examine if prior sepsis alters performance on cognitive and a broader range of behavioural tasks following acute immune challenge in order to understand to what extent exaggerated responses to subsequent infections may contribute to the decrement of quality of life associated with post-septic encephalopathy (Iwashyna et al. 2010) .
